✦ LIBER ✦

Tropisetron compared with a metoclopramide-based regimen in the prevention of chemotherapy-induced nausea and vomiting

✍ Scribed by Anderson, H.; Thatcher, N.; Howell, A.; Logan, K.; Sage, T.; de Bruijn, K.M.

Book ID: 122718045
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 831 KB
Volume: 30
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(94)90530-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intravenous metoclopramide: Prevention o

Intravenous metoclopramide: Prevention of chemotherapy-induced nausea and vomiting. A preliminary evaluation

✍ Stephen B. Strum; Jonathan E. McDermed; Joanne Pileggi; Laraine P. Riech; Helen 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 750 KB

Tropisetron (Navoban) in the prevention

Tropisetron (Navoban) in the prevention of chemotherapy-induced nausea and vomiting — the Nordic experience

✍ Bengt Sorbe; Håkan Andersson; Margareta Schmidt; Martin Söderberg; Thomas Högber 📂 Article 📅 1994 🏛 Springer-Verlag 🌐 English ⚖ 911 KB

Tropisetron in the prevention of radiati

Tropisetron in the prevention of radiation-induced nausea and vomiting

✍ Okkan, S.; Atahan, L.; Cakmak, A.; Haydaroglu, A.; Ozkok, S.; Pak, Y.; Sen, M.; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 354 KB

Tropisetron and metoclopramide in the pr

Tropisetron and metoclopramide in the prevention of postoperative nausea and vomiting : A comparative, placebo-controlled study in patients undergoing ophthalmic surgery

✍ T. ALI-MELKKILÄ; J. KANTO; R. KATEVUO 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 415 KB

Tropisetron in the prevention of nausea

Tropisetron in the prevention of nausea and vomiting in 131 children receiving cytotoxic chemotherapy

✍ Benoit, Yves ;Hulstaert, Frank ;Vermylen, Christiane ;Sariban, Eric ;Hoyoux, Cla 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 649 KB

## Abstract Tropisetron (Navoban®, Sandoz Pharma Ltd., Basel, Switzerland), a selective antagonist of the serotonin receptor (5‐HT3) dosed once‐daily at 0.2 mg/kg (with a maximum of 5 mg daily), was evaluated in the prevention of chemotherapy‐induced nausea and vomiting in 131 children with a media

Metoclopramide in the reduction of nause

Metoclopramide in the reduction of nausea and vomiting associated with combined chemotherapy

✍ Robert Cox; Christopher E. Newman; Michael J. Leyland 📂 Article 📅 1982 🏛 Springer 🌐 English ⚖ 276 KB